Daniel West to Hypoglycemic Agents
This is a "connection" page, showing publications Daniel West has written about Hypoglycemic Agents.
Connection Strength
1.091
-
An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial. Diab Vasc Dis Res. 2017 07; 14(4):336-344.
Score: 0.463
-
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2013 Aug; 36(8):2217-24.
Score: 0.351
-
Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes. Diabet Med. 2016 Apr; 33(4):506-10.
Score: 0.104
-
Comparison of appetite responses to high- and low-glycemic index postexercise meals under matched insulinemia and fiber in type 1 diabetes. Am J Clin Nutr. 2015 Mar; 101(3):478-86.
Score: 0.099
-
Improved end-stage high-intensity performance but similar glycemic responses after waxy barley starch ingestion compared to dextrose in type 1 diabetes. J Sports Med Phys Fitness. 2016 Nov; 56(11):1392-1400.
Score: 0.026
-
Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes. Diabet Med. 2014 Aug; 31(8):1009-13.
Score: 0.024
-
Impact of single and multiple sets of resistance exercise in type 1 diabetes. Scand J Med Sci Sports. 2015 Feb; 25(1):e99-109.
Score: 0.024